Browse current and past press releases from The Michael J. Fox Foundation.
-
-
-
Michael J. Fox Foundation Offers High-Quality LRRK2 Antibodies for PD Therapeutic Development
-
-
The Michael J. Fox Foundation Commits Up to $5.75 Million in Funding For 2010 Critical Challenges in Parkinson's Disease
-
Michael J. Fox Foundation Awards $1.1 Million for Clinical Trial of Transdermal Nicotine as Disease-Modifying Treatment for Parkinson's
-
The Michael J. Fox Foundation Awards $3.5 Million to Advance LRRK2 Therapeutic Development Efforts